Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of 5% lifitegrast eye drops for dry eye disease
ChiCTR2400092202Phase 3Completed
- Sponsor
- Xiamen Eye Center of Xiamen University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lifitegrast in dry eye syndrome (DED) (2 arms), sponsored by Xiamen Eye Center of Xiamen University. Primary endpoints: Visual Analog Scale and Corneal fluorescein staining score. Started Nov 2024; status: completed.
02
Drugs
lifitegrast
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on ChiCTR2400092202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092202.